Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
Lukas Baitsch, … , Nathalie Rufer, Daniel E. Speiser
Lukas Baitsch, … , Nathalie Rufer, Daniel E. Speiser
Published May 9, 2011
Citation Information: J Clin Invest. 2011;121(6):2350-2360. https://doi.org/10.1172/JCI46102.
View: Text | PDF
Research Article Immunology

Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients

  • Text
  • PDF
Abstract

In chronic viral infections, CD8+ T cells become functionally deficient and display multiple molecular alterations. In contrast, only little is known of self- and tumor-specific CD8+ T cells from mice and humans. Here we determined molecular profiles of tumor-specific CD8+ T cells from melanoma patients. In peripheral blood from patients vaccinated with CpG and the melanoma antigen Melan-A/MART-1 peptide, we found functional effector T cell populations, with only small but nevertheless significant differences in T cells specific for persistent herpesviruses (EBV and CMV). In contrast, Melan-A/MART-1–specific T cells isolated from metastases from patients with melanoma expressed a large variety of genes associated with T cell exhaustion. The identified exhaustion profile revealed extended molecular alterations. Our data demonstrate a remarkable coexistence of effector cells in circulation and exhausted cells in the tumor environment. Functional T cell impairment is mediated by inhibitory receptors and further molecular pathways, which represent potential targets for cancer therapy.

Authors

Lukas Baitsch, Petra Baumgaertner, Estelle Devêvre, Sunil K. Raghav, Amandine Legat, Leticia Barba, Sébastien Wieckowski, Hanifa Bouzourene, Bart Deplancke, Pedro Romero, Nathalie Rufer, Daniel E. Speiser

×

Figure 1

Naive and virus-specific T cells show no significant differences between melanoma patients and healthy donors.

Options: View larger image (or click on image) Download as PowerPoint
Naive and virus-specific T cells show no significant differences between...
(A and B) Volcano plots for all gene probes on the microarray, showing expression differences and P values of naive T cells (healthy donors [HDs] versus patients; A) or EBV-specific T cells (healthy donors versus patients; B). Each point represents 1 gene probe. (C) Lymphocytes were stained with an A2/EBV BMLF1280–288 tetramer together with anti-CD8, anti-CD45RA, and anti-CCR7. The inset shows a dot plot distinguishing the phenotypes among total CD8+ T cells analyzed as controls: naive (N) (CD45RA+CCR7+), central memory (CM) (CD45RA–CCR7+), effector memory (EM) (CD45RA–CCR7–) and effector memory RA+ cells (EMRA) (CD45RA+CCR7–). Bar graph depicts the percentage (mean ± SD) of each phenotype of total CD8+ cells or total EBV tetramer-positive populations from healthy donors or patients. (D) IFN-γ production by EBV-specific T cells upon 4-hour stimulation. Whiskers in box plots indicate maximum and minimum values measured. Cross indicates the mean, while line indicates the median.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts